What is wrong with Sun Pharma?
What is wrong with Sun Pharma?
Notwithstanding the problems inherited from Ranbaxy, Sun Pharma has its own legacy itself of severe manufacturing violations, including a stern Warning Letter from the US FDA on May 7, 2014. “These violations and deviations cause your drug products and APIs to be adulterated,” said the FDA.
What is the rank of Sun Pharma?
Sun Pharma is the No. 1 and largest pharmaceutical company in India with over 8% market share in the domestic market (AIOCD AWACS for 12 months ending June 2020). The company has been ranked No. 1 with over 11 different classes of doctors (SMSRC Prescription Data).
Why did Sun Pharma fall?
The weakness was largely down to the asset management business where the company said that sequential revenue fall was due to accrual of performance fees and sharing of profit on exit from alternate investment fund operations.
What is the future of Sun Pharma?
Analyst Future Growth Forecasts Revenue vs Market: SUNPHARMA’s revenue (10% per year) is forecast to grow slower than the Indian market (12.7% per year). High Growth Revenue: SUNPHARMA’s revenue (10% per year) is forecast to grow slower than 20% per year.
What is Sun Pharma famous for?
Sun Pharmaceuticals is the largest pharmaceutical company from India and the fifth largest specialty generic company in the world. It has capabilities across dosage forms like injectables, sprays, ointments, creams, liquids, tablets, and capsules.
Is Dilip Shanghvi a doctor?
Dilip Shanghvi (born 1 October 1955) is an Indian billionaire businessman and one of the country’s richest people….
| Dilip Shanghvi | |
|---|---|
| Born | 1 October 1955 Amreli, Gujarat, India |
| Alma mater | Bhawanipur Education Society College, University of Calcutta |
| Occupation | Founder and MD of Sun Pharmaceuticals |
| Spouse(s) | Vibha Shanghvi |
What is the net worth of Dilip Shanghvi?
13.1 billion USD (2021)
Dilip Shanghvi/Net worth
